LF+
Commercial- Indications
- Nutrition, Sports nutrition, Adult nutrition
Company intelligence / Profile preview
TurtleTree has pivoted from developing full cell-cultured milk to focusing on precision fermentation of high-value dairy bioactives. Its lead product LF+—lactoferrin produced via microbial fermentation—is slated as the world’s first industrial-scale animal-free lactoferrin. The company targets adult and infant nutrition markets with ingredients that support immunity and gut health. No traditional clinical trial results are reported as it operates in food/ingredient sectors rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TurtleTree.